Parametric Portfolio Associates’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $292K | Sell |
8,568
-7,716
| -47% | -$263K | ﹤0.01% | 3292 |
|
|
2021
Q4 | $629K | Sell |
16,284
-30,124
| -65% | -$1.16M | ﹤0.01% | 2963 |
|
|
2021
Q3 | $2.51M | Buy |
46,408
+35,654
| +332% | +$1.93M | ﹤0.01% | 2312 |
|
|
2021
Q2 | $360K | Sell |
10,754
-486
| -4% | -$16.3K | ﹤0.01% | 3201 |
|
|
2021
Q1 | $232K | Buy |
+11,240
| New | +$232K | ﹤0.01% | 3819 |
|
|
2019
Q4 | – | Sell |
-10,657
| Closed | -$23K | – | 3966 |
|
|
2019
Q3 | $23K | Buy |
+10,657
| New | +$23K | ﹤0.01% | 3925 |
|
|
2018
Q2 | – | Sell |
-3,733
| Closed | -$130K | – | 3887 |
|
|
2018
Q1 | $130K | Buy |
3,733
+354
| +10% | +$12.3K | ﹤0.01% | 3825 |
|
|
2017
Q4 | $144K | Buy |
3,379
+1,542
| +84% | +$65.7K | ﹤0.01% | 3794 |
|
|
2017
Q3 | $79K | Buy |
1,837
+1,123
| +157% | +$48.3K | ﹤0.01% | 3970 |
|
|
2017
Q2 | $26K | Sell |
714
-3,678
| -84% | -$134K | ﹤0.01% | 3976 |
|
|
2017
Q1 | $238K | Buy |
4,392
+94
| +2% | +$5.09K | ﹤0.01% | 3531 |
|
|
2016
Q4 | $228K | Buy |
4,298
+3,162
| +278% | +$168K | ﹤0.01% | 3544 |
|
|
2016
Q3 | $69K | Sell |
1,136
-3,894
| -77% | -$237K | ﹤0.01% | 3710 |
|
|
2016
Q2 | $331K | Buy |
5,030
+3,735
| +288% | +$246K | ﹤0.01% | 3404 |
|
|
2016
Q1 | $73K | Sell |
1,295
-425
| -25% | -$24K | ﹤0.01% | 3898 |
|
|
2015
Q4 | $404K | Sell |
1,720
-112
| -6% | -$26.3K | ﹤0.01% | 3389 |
|
|
2015
Q3 | $290K | Sell |
1,832
-1,556
| -46% | -$246K | ﹤0.01% | 2979 |
|
|
2015
Q2 | $1.28M | Sell |
3,388
-151
| -4% | -$57.1K | ﹤0.01% | 2601 |
|
|
2015
Q1 | $1.48M | Buy |
3,539
+157
| +5% | +$65.7K | ﹤0.01% | 2482 |
|
|
2014
Q4 | $926K | Buy |
3,382
+792
| +31% | +$217K | ﹤0.01% | 2841 |
|
|
2014
Q3 | $503K | Buy |
2,590
+1,220
| +89% | +$237K | ﹤0.01% | 3201 |
|
|
2014
Q2 | $335K | Buy |
1,370
+104
| +8% | +$25.4K | ﹤0.01% | 3456 |
|
|
2014
Q1 | $336K | Sell |
1,266
-223
| -15% | -$59.2K | ﹤0.01% | 3381 |
|
|
2013
Q4 | $541K | Buy |
1,489
+593
| +66% | +$215K | ﹤0.01% | 3112 |
|
|
2013
Q3 | $476K | Sell |
896
-20
| -2% | -$10.6K | ﹤0.01% | 3128 |
|
|
2013
Q2 | $215K | Buy |
+916
| New | +$215K | ﹤0.01% | 3441 |
|